LSTA logo

Lisata Therapeutics (LSTA) Shareholders Equity

Annual Shareholders Equity

$48.15 M
-$18.43 M-27.68%

31 December 2023

LSTA Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$33.69 M
-$4.56 M-11.92%

30 September 2024

LSTA Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LSTA Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--30.0%
3 y3 years-47.8%-63.5%
5 y5 years+131.3%+61.9%

LSTA Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-47.8%at low-63.5%at low
5 y5 years-47.8%+131.3%-69.5%+95.4%
alltimeall time-47.8%+2592.4%-69.5%+1435.0%

Lisata Therapeutics Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$33.69 M(-11.9%)
June 2024
-
$38.25 M(-11.0%)
Mar 2024
-
$43.00 M(-10.7%)
Dec 2023
$48.15 M(-27.7%)
$48.15 M(-9.1%)
Sept 2023
-
$52.96 M(-8.6%)
June 2023
-
$57.97 M(-4.9%)
Mar 2023
-
$60.96 M(-8.4%)
Dec 2022
$66.58 M(-27.8%)
$66.58 M(-7.6%)
Sept 2022
-
$72.03 M(-12.6%)
June 2022
-
$82.39 M(-6.9%)
Mar 2022
-
$88.50 M(-4.1%)
Dec 2021
$92.25 M(+183.9%)
-
Dec 2021
-
$92.25 M(-6.5%)
Sept 2021
-
$98.67 M(-6.0%)
June 2021
-
$104.93 M(-4.8%)
Mar 2021
-
$110.27 M(+239.3%)
Dec 2020
$32.50 M(+56.1%)
$32.50 M(-13.9%)
Sept 2020
-
$37.74 M(+11.6%)
June 2020
-
$33.81 M(+96.1%)
Mar 2020
-
$17.24 M(-17.2%)
Dec 2019
$20.82 M(-44.8%)
$20.82 M(-17.6%)
Sept 2019
-
$25.25 M(-15.5%)
June 2019
-
$29.89 M(-13.9%)
Mar 2019
-
$34.73 M(-7.9%)
Dec 2018
$37.73 M(-25.3%)
$37.73 M(-8.2%)
Sept 2018
-
$41.08 M(-6.1%)
June 2018
-
$43.74 M(-4.1%)
Mar 2018
-
$45.59 M(-9.7%)
Dec 2017
$50.51 M(+934.2%)
$50.51 M(-5.3%)
Sept 2017
-
$53.33 M(-2.0%)
June 2017
-
$54.42 M(-6980.0%)
Mar 2017
-
-$791.00 K(-116.2%)
Dec 2016
$4.88 M(-79.4%)
$4.88 M(-54.6%)
Sept 2016
-
$10.75 M(+77.6%)
June 2016
-
$6.05 M(-55.7%)
Mar 2016
-
$13.66 M(-42.4%)
Dec 2015
$23.71 M(-59.5%)
$23.71 M(-57.2%)
Sept 2015
-
$55.43 M(-16.5%)
June 2015
-
$66.38 M(+31.7%)
Mar 2015
-
$50.40 M(-13.9%)
Dec 2014
$58.51 M(-6.4%)
$58.51 M(-7.1%)
Sept 2014
-
$63.00 M(-19.3%)
June 2014
-
$78.04 M(+30.8%)
Mar 2014
-
$59.64 M(-4.6%)
Dec 2013
$62.54 M(+88.5%)
$62.54 M(+75.2%)
Sept 2013
-
$35.70 M(+6.7%)
June 2013
-
$33.46 M(+13.7%)
Mar 2013
-
$29.43 M(-11.3%)
Dec 2012
$33.18 M(-46.5%)
$33.18 M(-31.2%)
Sept 2012
-
$48.21 M(+4.0%)
June 2012
-
$46.35 M(-26.9%)
Mar 2012
-
$63.37 M(+2.2%)
DateAnnualQuarterly
Dec 2011
$62.03 M(+27.5%)
$62.03 M(-15.7%)
Sept 2011
-
$73.56 M(+17.7%)
June 2011
-
$62.51 M(-3.8%)
Mar 2011
-
$65.00 M(+33.6%)
Dec 2010
$48.66 M(+103.5%)
$48.66 M(+6.6%)
Sept 2010
-
$45.64 M(-4.5%)
June 2010
-
$47.80 M(+59.7%)
Mar 2010
-
$29.93 M(+25.2%)
Dec 2009
$23.91 M(+2670.3%)
$23.91 M(-1418.1%)
Sept 2009
-
-$1.81 M(-147.8%)
June 2009
-
$3.79 M(-571.8%)
Mar 2009
-
-$804.40 K(-193.2%)
Dec 2008
$863.20 K(-74.0%)
$863.20 K(-52.8%)
Sept 2008
-
$1.83 M(+5.6%)
June 2008
-
$1.73 M(-18.1%)
Mar 2008
-
$2.11 M(-36.2%)
Dec 2007
$3.32 M(+1035.3%)
$3.32 M(-18.4%)
Sept 2007
-
$4.07 M(+2382.1%)
June 2007
-
$163.80 K(-88.0%)
Mar 2007
-
$1.36 M(+365.8%)
Dec 2006
$292.10 K(-116.1%)
$292.10 K(-78.9%)
Sept 2006
-
$1.39 M(-223.8%)
June 2006
-
-$1.12 M(+9.9%)
Mar 2006
-
-$1.02 M(-44.0%)
Dec 2005
-$1.82 M(-5.9%)
-$1.82 M(-28.0%)
Sept 2005
-
-$2.52 M(+9.9%)
June 2005
-
-$2.30 M(+10.6%)
Mar 2005
-
-$2.08 M(+7.4%)
Dec 2004
-$1.93 M(+28.5%)
-$1.93 M(+15.5%)
Sept 2004
-
-$1.67 M(-12.3%)
June 2004
-
-$1.91 M(+3.4%)
Mar 2004
-
-$1.84 M(+22.7%)
Dec 2003
-$1.50 M(+82.4%)
-$1.50 M(+10.7%)
Sept 2003
-
-$1.36 M(+14.4%)
June 2003
-
-$1.19 M(+23.4%)
Mar 2003
-
-$961.80 K(+16.7%)
Dec 2002
-$823.90 K(-320.5%)
-$823.90 K(+85.4%)
Sept 2002
-
-$444.40 K(+108.1%)
June 2002
-
-$213.50 K(-750.9%)
Mar 2002
-
$32.80 K(-91.2%)
Dec 2001
$373.70 K(-84.7%)
$373.70 K(-65.9%)
Sept 2001
-
$1.10 M(-25.3%)
June 2001
-
$1.47 M(-18.7%)
Mar 2001
-
$1.81 M(-26.2%)
Dec 2000
$2.45 M(-37.5%)
$2.45 M(-33.3%)
Sept 2000
-
$3.67 M(-20.4%)
June 2000
-
$4.61 M(-9.6%)
Mar 2000
-
$5.10 M
Dec 1999
$3.92 M(-1374.3%)
-
Dec 1998
-$307.80 K(+1182.5%)
-
Mar 1998
-$24.00 K(-96.3%)
-
Mar 1997
-$651.70 K(+104.2%)
-
Mar 1996
-$319.10 K
-

FAQ

  • What is Lisata Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Lisata Therapeutics?
  • What is Lisata Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Lisata Therapeutics?
  • What is Lisata Therapeutics quarterly shareholders equity year-on-year change?

What is Lisata Therapeutics annual stockholders equity?

The current annual shareholders equity of LSTA is $48.15 M

What is the all time high annual shareholders equity for Lisata Therapeutics?

Lisata Therapeutics all-time high annual stockholders equity is $92.25 M

What is Lisata Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of LSTA is $33.69 M

What is the all time high quarterly shareholders equity for Lisata Therapeutics?

Lisata Therapeutics all-time high quarterly stockholders equity is $110.27 M

What is Lisata Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, LSTA quarterly stockholders equity has changed by -$14.46 M (-30.03%)